Genetic and Genomic Approaches to Drug-Induced Liver Injury
Author Information
Author(s): Ann K. Daly
Primary Institution: Newcastle University
Hypothesis
Identifying genetic risk factors for drug-induced liver injury (DILI) can help prevent adverse drug reactions.
Conclusion
Genetic factors, particularly specific human leucocyte antigen (HLA) alleles, play a significant role in the susceptibility to drug-induced liver injury.
Supporting Evidence
- Specific HLA alleles are associated with increased risk of DILI.
- Genome-wide association studies have identified multiple genetic risk factors for DILI.
- Polygenic risk scores have been developed to predict susceptibility to DILI.
- Genetic factors can help identify patients at risk for drug-induced liver injury.
Takeaway
Some people can get sick from certain medicines because of their genes, and scientists are trying to find out why.
Methodology
The study involved genome-wide association studies (GWAS) to identify genetic risk factors for DILI.
Potential Biases
The majority of genetic studies have not included diverse populations, which may introduce bias in understanding genetic susceptibility.
Limitations
Most studies have focused on White Europeans, limiting the applicability of findings to other ethnic groups.
Participant Demographics
Primarily White Europeans, with limited data on other ethnicities.
Statistical Information
P-Value
1.4×10−47
Confidence Interval
3.66–2.69
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website